Thursday, April 16, 2020
10:00 - 11:00 a.m. PDT
1:00 - 2:00 p.m. EDT
19:00 - 20:00 CEST
Life sciences companies often invoke the attorney-client privilege and work-product doctrine to withhold protected information during patent litigation. Properly withholding a company’s own information, while also identifying and challenging the other side’s improper withholding of information, requires a strong understanding of the rules and their nuances.
Companies should work from the earliest stages of product development to establish procedures for properly protecting documents and information under the attorney-client privilege and the work product doctrine. Failing to do so may lead to the regretful position of competitors gaining access to information they were never intended to have.
Please join us as we discuss the attorney-client privilege and the work-product doctrine in life sciences patent cases, including: